The imminent need for transition to a circular bioeconomy, based on the valorisation of
renewable biomass feedstocks, will ameliorate global challenges induced by climate …

Degradable polymers (both biomacromolecules and several synthetic polymers) for
biomedical applications have been promising very much in the recent past due to their low …

Ulvan, a sulphated polysaccharide located in the cell walls of green algae that possesses
unique structural properties albeit its repeating unit shares chemical affinity with …

Marine biopolymers, abundantly present in seaweeds and marine animals, feature diverse
structures and functionalities, and possess a wide range of beneficial biological activities …

The species of green macroalga belonging to the genus Ulva (family: Ulvaceae) are utilized
in various fields, from food supplements to biomedical applications. Ulvan, a polysaccharide …

Controlled, localized drug delivery is a long-standing goal of medical research, realization of
which could reduce the harmful side-effects of drugs and allow more effective treatment of …

Given their native-like biological properties, high growth factor retention capacity and porous
nature, sulfated-polysaccharide-based scaffolds hold great promise for a number of tissue …

The macroalgal hydrocolloid industry is a rapidly growing industry with an annual growth in
the global production of 2–3%. Hydrocolloids from macroalgae are mainly in the form of …

Over the past two decades numerous studies have been reported on seaweeds‐derived
polysaccharides for biomedical and biological applications (tissue engineering, drug …

Sulphated polysaccharides (SP) extracted from seaweeds have antiviral properties and are
much less cytotoxic than conventional drugs, but little is known about their mode of action …